BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 68240)

  • 21. Cyproheptadine for Cushing's disease (cont.).
    Scott R; Espiner EA; Donald RA
    N Engl J Med; 1977 Jan; 296(1):57-8. PubMed ID: 830282
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of cushing's disease with cypropheptadine (author's transl)].
    Michelsen H; Contreras P; Bradford I; Rojas A
    Rev Med Chil; 1977 Jun; 105(6):380-3. PubMed ID: 331429
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two pregnancies in a woman with Cushing's syndrome treated with cyproheptadine. Case report.
    Kasperlik-Załuska A; Migdalska B; Hartwig W; Wilczyńska J; Marianowski L; Stopińska-Głuszak U; Lozińska D
    Br J Obstet Gynaecol; 1980 Dec; 87(12):1171-3. PubMed ID: 7437385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV; Luchitskiĭ EV; Iakovlev AA
    Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cushing's syndrome.
    McPherson HT
    Urol Clin North Am; 1977 Jun; 4(2):211-26. PubMed ID: 197679
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyproheptadine in the control of Cushing's disease.
    Hsu TH; Gann DS; Tsan KW; Russell RP
    Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More on cyproheptadine in Cushing's disease.
    N Engl J Med; 1977 Mar; 296(10):576-7. PubMed ID: 189191
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolonged remission of a case of Cushing's disease following cessation of cyproheptadine therapy.
    Wiesen M; Ross F; Krieger DT
    Acta Endocrinol (Copenh); 1983 Mar; 102(3):436-8. PubMed ID: 6829265
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.
    Komissarenko IV; Cheban AK; Rybakov SI; Pomerantsev YuV ; Slavnov VI; Luchitskii EV
    Neurosci Behav Physiol; 1982; 12(6):494-6. PubMed ID: 6314174
    [No Abstract]   [Full Text] [Related]  

  • 31. Pregnancy after cyproheptadine treatment for Cushing's disease.
    Griffith DN; Rose EJ
    N Engl J Med; 1981 Oct; 305(15):893-4. PubMed ID: 7278892
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyproheptadine-induced remission of Cushing's disease.
    Krieger DT; Amorosa L; Linick F
    N Engl J Med; 1975 Oct; 293(18):893-6. PubMed ID: 1177986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment.
    van Waveren Hogervorst CO; Koppeschaar HP; Zelissen PM; Lips CJ; Garcia BM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):652-5. PubMed ID: 8636284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
    Vetter W; Vetter H; Beckerhoff R; Würsten D; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1320-2. PubMed ID: 1034340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyproheptadin in the treatment of Cushing's syndrome (author's transl)].
    Matys Z; Marek J; Gregorová I
    Sb Lek; 1977 Aug; 79(7-8):226-30. PubMed ID: 905761
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and management of Cushing's syndrome.
    Newell-Price J; Grossman A
    Lancet; 1999 Jun; 353(9170):2087-8. PubMed ID: 10382687
    [No Abstract]   [Full Text] [Related]  

  • 37. [Non-invasive therapy of Cushing's syndrome].
    Miura K
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1627-32. PubMed ID: 7798761
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
    Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract]   [Full Text] [Related]  

  • 40. The medical treatment of Cushing's syndrome.
    Miller JW; Crapo L
    Endocr Rev; 1993 Aug; 14(4):443-58. PubMed ID: 7693447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.